Precision Business Insights


Insomnia Management Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

The Insomnia Management Market: By Therapy Type (Non-pharmacological Therapy (Hypnotherapy, Cognitive Behavioural Therapy, Medical Devices, and Other Non-pharmacological Therapy) and Pharmacological Therapy (Prescription Sleep Aids and Over-The-Counter Sleep Aids)) By End User(Hospitals, Ambulatory Surgical Centres, Homecare Settings), By Geography


Insomnia Management Market


Market Outline: Insomnia Management Market

Insomnia is a sleeping disorder where in the individual faces troublesomely to rest or remain asleep. The signs incorporate wretchedness, touchiness, low stamina and daytime drowsiness. It is a very transcendent issue that influences a huge number of individuals, all around. Sleep deprivation related conditions are caused because of interruption in circadian cadence, endless agony, hyperthyroidism, menopause, mental pressure, and other medicinal conditions. Besides, use of medications, for example, liquor, nicotine and caffeine will prompt a sleeping disorder.


Market Dynamics: Insomnia Management Market 

Expanding effectiveness of medications, which is for the most part ascribed to developing bioavailability of these medications, are probably going to upgrade Insomnia Management market in the forthcoming years. Advancement of new medication definitions for enhancing adequacy of medications is foreseen to remain a key technique among pharmaceutical ventures. In spite of the fact that there are a few medications accessible in the market for treatment of a sleeping disorder, delayed utilization of dominant part of these medications has been related with reliance and habit. This has additionally required the necessity of treatment under therapeutic supervision. Developing geriatric populace is relied upon to remain a key factor driving interest for a sleeping disorder treatment. What’s more, mounting rates of mental issue alongside rising feelings of anxiety among the urban populace has additionally made interest for Insomnia Management market.


Market Scope: Insomnia Management Market 

The Insomnia Management Market is classified on the basis of Therapy Type, end user and geographical regions.

Based on Therapy Type, Insomnia Management Market is segmented into

  • Non-pharmacological Therapy
  • Hypnotherapy
  • Cognitive Behavioural Therapy
  • Medical Devices
  • Other Non-pharmacological Therapy)
  • Pharmacological Therapy
  • Prescription Sleep Aids
  • Over-The-Counter Sleep Aids

Based on End User, Insomnia Management Market is segmented into

  • Hospitals
  • Ambulatory Surgical Centres
  • Homecare Settings
  • Others


North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Market Summary: Insomnia Management Market 

The worldwide sleep deprivation Insomnia Management is exceedingly divided with a few producers offering generics. Although a couple of players offer marked medications, value affectability is an issue in a few locales. Organizations centre on growing new synthetic elements and novel atoms to acquire higher income share. Novel sedate improvement and mechanical advances in therapeutic gadgets are relied upon to support rivalry in this market. The divided generics segment may witness development in the quantity of new contestants’ because of lesser section hindrances in the Insomnia Management market. On August 14, 2014 Merck got FDA endorsement for its Insomnia management. i.e. Belsomra (suvorexant). The FDA has endorsed this medication in four distinct qualities i.e. 5 mg, 10 mg, 15 mg and 20 mg. In January, 2014, the Vanda Pharmaceuticals Inc. has gotten endorsement for sleep deprivation item i.e. Helitoz trasimelteon.


Regional Analysis: Insomnia Management Market 

Geographically Insomnia Management Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America was driving Insomnia Management market. Developing interest for Insomnia in the U.S. Furthermore, Canada combined with expanding predominance of sleep issue, increment in mindfulness, and high medicinal services spending are foreseen to drive the market. Besides, high predominance of this infection among geriatric populace and quickly developing geriatric populace in the U.S. are relied upon to be the key driving elements advancing interest. Likewise, good repayment approaches for remedial items, solid clinical pipeline, and rising feeling of anxiety are different variables foreseen to advance income development. North America was trailed by Asia Pacific, which represented 20.9% of the aggregate market income in 2016. Japan has a noteworthy commitment in the market inferable from high predominance of target infection and it is assessed that one out of five individuals in Japan experience the ill effects of the same. Developing economies, for example, India, China, and Indonesia have been utilizing generics and marked generics because of the monetary valuing of nonspecific options. Developing interest for new treatment choices and rising commonness is relied upon to drive development amid the forecast period.


Market participants: Insomnia Management Market 

Some of the players in Insomnia Management Market

  • Meda Consumer Healthcare Inc. (U.S.)
  • Eisai Co., Ltd. (Japan)
  • Merck & Co., Inc. (U.S.)
  • Pfizer, Inc. (U.S.)
  • Pernix Therapeutics Holdings (U.S.)
  • Sanofi S.A. (France)
  • Vanda Pharmaceuticals, Inc (U.S.)
  • Takeda Pharmaceutical Company Ltd. (Japan)